Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-745-8 | CAS number: 65405-77-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1999-07-19 to 1999-07-23
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was performed in line with good scientific principles and reported to a good standard. Some limitations are present in the reporting of the test substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
- Study type:
- study with volunteers
- Endpoint addressed:
- skin irritation / corrosion
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Volunteers were patch tested with the test substance at three concentrations of 2, 6 and 12 % in EtOH/DEP 1:1. The patch was kept in place for 48 hours and then assessed at 72 and 96 hours for signs of reactions. All volunteers were recruited giving written and informed consent.
- GLP compliance:
- no
Test material
- Reference substance name:
- (Z)-3-hexenyl salicylate
- EC Number:
- 265-745-8
- EC Name:
- (Z)-3-hexenyl salicylate
- Cas Number:
- 65405-77-8
- Molecular formula:
- C13H16O3
- IUPAC Name:
- hex-3-en-1-yl salicylate
- Test material form:
- not specified
Constituent 1
Method
- Type of population:
- general
- Subjects:
- - Number of subjects exposed: 50
- Sex: Male (20) and Female (30)
- Age: 24-69 years
- Race: Caucasian
- Known diseases: Subjects with healthy skin at the test site were included in the study.
At the beginning of the test, the dermatologist created an anamnesis for each volunteer. The results of the skin history was used to select the suitability of the volunteers. Three of the volunteers had a drug allergy, ten volunteers had allergic rhinitis, two of the volunteers had cradle cap, eight of the volunteers had a contact allergy, one volunteer had a food allergy, one volunteer had atopic eczema and one volunteer had an insect sting allergy. Volunteers who had cradle cap, allergic rhinitis, allergic asthma or atopic eczema were identified as atopics. Eleven volunteers were characterised as having sensitive skin (Numbers 3, 6, 9, 14, 17, 24, 33, 36, 43, 47 and 50) equating to 22% of the study population. In addition the atopic score was ascertained according to Diepgen et al (1989), Acta. Derm. Venereol (Stockh.) Suppl. 144: 50-54 to more accurately characterise the groups. As a result of this assessment, five volunteers (Numbers 2, 15, 19, 33 and 36) were characterised as also having sensitive skin.
- Inclusion criteria: Healthy skin at the test site, not taking long-term medication that could influence the test results.
- Exclusion criteria: Taking medication that increases the sensitivity of the subject especially the skin, pregnant or lactating women and persons who had participated in a patch test during the last three months. - Ethical approval:
- confirmed and informed consent free of coercion received
- Remarks:
- In accordance with The World Medical Association, World Medical Association, Declaration of Helsinki, Fernay, Voltaire, France (1989)
- Route of exposure:
- dermal
- Reason of exposure:
- intentional
- Exposure assessment:
- measured
- Details on exposure:
- Volunteers were patch tested with the test substance at three concentrations of 2, 6 and 12% in EtOH/DEP 1:1. The test substance was applied to the back of each volunteer under occlusive cutaneous test plasters. After a test period of 48 hours the test plasters were removed and the test area was assessed. Further assessments were performed after 72 and 96 hours. To standardise the test, a blank plaster without product and two well tolerated standard products were tested. Standard L was an oil-water emulsion. The other control, Standard N was a water-oil emulsion. Both these products were considered to be well tolerated by the skin. In addition, a positive control, sodium dodecylsulphate solution (SDS) 0.3% aqueous solution, was used as a positive control, and a negative control of deionised water was also included.
- Examinations:
- - Time of observations: Performed at removal of patch and at 72 hours and 96 hours post exposure.
- Evaluation criteria: Presented in table 1
Results and discussion
- Results of examinations:
- - Standard products: No reaction of erythema was documented for the untreated area. Deionised water produced four slight reactions and one clear reaction of erythema. The application of Standard product L caused two slight reactions of erythema and Standard product N induced one slight reaction of erythema. From the results of the standards, it was inferred that two slight reactions would be expected with the test substance in this study with well tolerated products.
- Results of test products: HR 99/600301 A caused skin irritation in two volunteers (Numbers 7 and 48); two slight erythema reactions were noted. HR 99/600301 B and HR 99/600301 C caused no skin irritation during the whole test.
Any other information on results incl. tables
Table 2: Summary of results
Reaction points | ||||
Product | 48 hours | 72 hours | 96 hours | Sum |
Untreated area | 0 | 0 | 0 | 0 |
Aqua derm. | 3 | 2 | 1 | 6 |
Standard L | 0 | 0 | 2 | 2 |
Standard N | 0 | 0 | 1 | 1 |
Sodium dodecylsulphate (0.3%) | 11 | 46 | 33 | 90 |
HR 99/600301A (2 %) | 0 | 1 | 1 | 2 |
HR 99/600301B (6 %) | 0 | 0 | 0 | 0 |
HR 99/600301C (12 %) | 0 | 0 | 0 | 0 |
Applicant's summary and conclusion
- Conclusions:
- The test substance was found to be well tolerated by the skin under the conditions of the study at concentrations of 2, 6 and 12 %.
- Executive summary:
The skin irritation potential of the test substance was assessed in 50 human volunteers using a single application patch test. Test substance at concentrations of 2, 6 and 12% in EtOH/DEP 1:1 was applied to the back of each volunteer under occlusive cutaneous test plasters.
After a test period of 48 hours the test plasters were removed and the test area was assessed. Further assessments were performed after 72 and 96 hours. With the exception of two slight reactions noted in the 2% product, the test substance was found to be well tolerated by the skin under the conditions of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.